InsidersTradesSigma
Browse the full directors' dealings record of Ascelia Pharma AB, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Ascelia Pharma AB has logged 6 public disclosures. Market capitalisation: €393.3m. The latest transaction was reported on 26 November 2025 (Purchase). Among the most active insiders: Magnus Olafsson Corfitzen. Every trade is openly available.
FY ended December 2025 · cache
0 of 0 declarations